SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001338095-17-000015
Filing Date
2017-03-15
Accepted
2017-03-15 17:01:16
Documents
17
Period of Report
2017-03-15
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nrx8-kfebruary2017mor_0315.htm 8-K 35587
2 EXHIBIT 99.1 di358februarymor.htm EX-99.1 4447
3 di358februarymor001.jpg GRAPHIC 94981
4 di358februarymor002.jpg GRAPHIC 25887
5 di358februarymor003.jpg GRAPHIC 14415
6 di358februarymor004.jpg GRAPHIC 120602
7 di358februarymor005.jpg GRAPHIC 217418
8 di358februarymor006.jpg GRAPHIC 140223
9 di358februarymor007.jpg GRAPHIC 81873
10 di358februarymor008.jpg GRAPHIC 109413
11 di358februarymor009.jpg GRAPHIC 115514
12 di358februarymor010.jpg GRAPHIC 140211
13 di358februarymor011.jpg GRAPHIC 73694
14 di358februarymor012.jpg GRAPHIC 82423
15 di358februarymor013.jpg GRAPHIC 154284
16 di358februarymor014.jpg GRAPHIC 102452
17 di358februarymor015.jpg GRAPHIC 121663
  Complete submission text file 0001338095-17-000015.txt   2206092
Mailing Address P.O. BOX 400 JAMISON PA 18929
Business Address P.O. BOX 400 JAMISON PA 18929 6095538887
NephroGenex, Inc. (Filer) CIK: 0001338095 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36303 | Film No.: 17691921
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences